Aberrant CDH3 expression is associated with an aggressive phenotype in various tumors, including gliomas, where its elevated levels correlate with a poor prognosis, likely due to its regulation of glial cell viability, invasion, migration, and stemness [63,64,65,66]. This evidence concerns the gene CDH3 and central nervous system cancer.